A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

Completed · Phase 1 · Has a placebo group

Conditions studied: Liver Fibrosis/NASH

In brief

The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.

Key facts

Study ID

NCT02538874

Run by

Bristol-Myers Squibb

People needed

275

Starts

2015-10-31

Expected to finish

2016-11-05

Last updated by the study team

2017-05-24

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 21 to 55 years (Part A,B, and C)
• BMI 30-40 (Part A or Part B); BMI 20-35 (Part C). BMI = weight (kg)/ [height (m)]

You may not qualify if…

• Any significant medical illness
• Cannot tolerate subcutaneous injections, or having blood samples taken
• Smoking more than 10 cigarettes/day
• History of allergy to pegylated compounds or of hypersensitivity to protein based therapeutics.
• HIV, Hepatitis B virus (HBV) or Hepatitis C virus (HCV) infection.
• Pregnancy

Where it is running

• Profil Institute For Clinical Research, Inc. — Chula Vista, California, United States
• Wcct Global, Llc — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.